{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:42:31Z","timestamp":1792251751418,"version":"4.4.0"},"reference-count":24,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":3059,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To improve prognosis, it is important to predict the incidence of renal failure and cardiovascular disease in type 2 diabetic patients before the progression to advanced nephropathy. We investigated the predictive effects of urinary liver-type fatty acid\u2013binding protein (L-FABP), which is associated with renal tubulointerstitial damage, in renal and cardiovascular prognosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Japanese type 2 diabetic patients (n = 618) with serum creatinine \u22641.0 mg\/dL and without overt proteinuria were enrolled between 1996 and 2000 and followed up until 2011. Baseline urinary L-FABP was measured with an enzyme-linked immunosorbent assay. The primary end points were renal and cardiovascular composites (hemodialysis, myocardial infarction, angina pectoris, stroke, cerebral hemorrhage, and peripheral vascular disease). The secondary renal outcomes were the incidence of a 50% decline in estimated glomerular filtration rate (eGFR), progression to an eGFR &amp;lt;30 mL\/min\/1.73 m2, and the annual decline rate in eGFR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>During a 12-year median follow-up, 103 primary end points occurred. The incidence rate of the primary end point increased in a stepwise manner with increases in urinary L-FABP. In Cox proportional hazards analysis, the adjusted hazard ratio in patients with the highest tertile of urinary L-FBAP was 1.93 (95% CI 1.13\u20133.29). This relationship was observed even when analyzed separately in normoalbuminuria and microalbuminuria. Patients with the highest tertile of urinary L-FABP also demonstrated a higher incidence of the secondary renal outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our results indicate that urinary L-FABP may be a predictive marker for renal and cardiovascular prognosis in type 2 diabetic patients without advanced nephropathy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc12-1298","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T03:02:08Z","timestamp":1354762928000},"page":"1248-1253","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":84,"title":["Predictive Effects of Urinary Liver-Type Fatty Acid\u2013Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy"],"prefix":"10.2337","volume":"36","author":[{"given":"Shin-ichi","family":"Araki","sequence":"first","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Haneda","sequence":"additional","affiliation":[{"name":"Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical College, Asahikawa, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Koya","sequence":"additional","affiliation":[{"name":"Division of Diabetology and Endocrinology, Department of Medicine, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sugaya","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Isshiki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kume","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Kashiwagi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Uzu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Maegawa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,4,13]]},"reference":[{"key":"2022031219325966800_B1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc12-s011","article-title":"Standards of medical care in diabetes\u20142012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031219325966800_B2","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2337\/db06-1646","article-title":"Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes","volume":"56","author":"Araki","year":"2007","journal-title":"Diabetes"},{"key":"2022031219325966800_B3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","article-title":"Changes in albuminuria predict mortality and morbidity in patients with vascular disease","volume":"22","author":"Schmieder","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2022031219325966800_B4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031219325966800_B5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/dc10-2251","article-title":"Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008","volume":"34","author":"Ford","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031219325966800_B6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2010040354","article-title":"Risk for ESRD in type 1 diabetes remains high despite renoprotection","volume":"22","author":"Rosolowsky","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2022031219325966800_B7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2022031219325966800_B8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ki.2011.223","article-title":"Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Herzog","year":"2011","journal-title":"Kidney Int"},{"key":"2022031219325966800_B9","doi-asserted-by":"crossref","first-page":"R1009","DOI":"10.1152\/ajpregu.00809.2010","article-title":"The proximal tubule in the pathophysiology of the diabetic kidney","volume":"300","author":"Vallon","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022031219325966800_B10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1042\/bj2730759","article-title":"Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization","volume":"273","author":"Maatman","year":"1991","journal-title":"Biochem J"},{"key":"2022031219325966800_B11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000168653","article-title":"Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin","volume":"13","author":"Thomas","year":"1993","journal-title":"Am J Nephrol"},{"key":"2022031219325966800_B12","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1046\/j.1523-1755.2002.00618.x","article-title":"Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage","volume":"62","author":"Kamijo","year":"2002","journal-title":"Kidney Int"},{"key":"2022031219325966800_B13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2169\/internalmedicine.39.783","article-title":"Evaluation of a new care system provided to diabetic patients in the outpatient clinic","volume":"39","author":"Hidaka","year":"2000","journal-title":"Intern Med"},{"key":"2022031219325966800_B14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the Committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","year":"2010","journal-title":"J Diabetes Invest"},{"key":"2022031219325966800_B15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lab.2003.08.001","article-title":"Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease","volume":"143","author":"Kamijo","year":"2004","journal-title":"J Lab Clin Med"},{"key":"2022031219325966800_B16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2022031219325966800_B17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2006080872","article-title":"Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes","volume":"18","author":"Perkins","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2022031219325966800_B18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ndt\/gfn573","article-title":"Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice","volume":"24","author":"Kamijo-Ikemori","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2022031219325966800_B19","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2353\/ajpath.2009.080780","article-title":"Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage","volume":"174","author":"Yokoyama","year":"2009","journal-title":"Am J Pathol"},{"key":"2022031219325966800_B20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2337\/dc10-1392","article-title":"Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients","volume":"34","author":"Kamijo-Ikemori","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031219325966800_B21","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc09-2242","article-title":"Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients","volume":"33","author":"Nielsen","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031219325966800_B22","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ki.2010.554","article-title":"Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy","volume":"79","author":"Nielsen","year":"2011","journal-title":"Kidney Int"},{"key":"2022031219325966800_B23","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/diacare.28.11.2728","article-title":"Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy","volume":"28","author":"Nakamura","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031219325966800_B24","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/dc09-0429","article-title":"Tubular and glomerular injury in diabetes and the impact of ACE inhibition","volume":"32","author":"Nielsen","year":"2009","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/5\/1248\/614997\/1248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/5\/1248\/614997\/1248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:10:05Z","timestamp":1647119405000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/36\/5\/1248\/29320\/Predictive-Effects-of-Urinary-Liver-Type-Fatty"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,13]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,4,13]]},"published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc12-1298","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,13]]}}}